We are live on ! Find out more
CMPS

Compass Pathways

103 hedge funds and large institutions have $81.1M invested in Compass Pathways in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more capital invested

Capital invested by funds: $61M → $81.1M (+$20.1M)

1.29% more ownership

Funds ownership: 17.85%19.14% (+1.3%)

9% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 23

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

7% less funds holding

Funds holding: 111103 (-8)

23% less call options, than puts

Call options by funds: $2.57M | Put options by funds: $3.33M

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

Holders
103
Holders Change
-8
Holders Change %
-7.21%
% of All Funds
1.64%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
25
Reduced
23
Closed
12
Calls
$2.57M
Puts
$3.33M
Net Calls
-$760K
Net Calls Change
-$801K

CMPS Hedge Fund Activity: Q1 2023 in Review

103 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Compass Pathways (CMPS) for Q1 2023, worth a combined $81.1M — up 33% from $61M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of CMPS and 7 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 25 added.

The largest buyer was ARK Investment Management, adding an estimated $12.1M. The largest seller was PFM Health Sciences, cutting an estimated $2.43M.

  • 103 institutional investors held Compass Pathways (CMPS) as of Q1 2023, down from 111 in Q4 2022.
  • Funds reported $81.1M of Compass Pathways stock for Q1 2023, up 33% quarter-over-quarter.
  • 7 funds opened new Compass Pathways positions in Q1 2023 and 12 closed out, a net change of -5 holders.
  • The largest Compass Pathways buyer in Q1 2023 was ARK Investment Management, an estimated $12.1M added.
  • The largest Compass Pathways seller in Q1 2023 was PFM Health Sciences, an estimated $2.43M sold.

Based on aggregated 13F filings for Q1 2023.